Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05327868 · ClinicalTrials.gov registry record · NA

Lean and Obese: Dietary Inflammation

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT05327868 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05327868, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

In the Lean and Obese Dietary Inflammation (LODI) study, the primary goal is to determine the effect of short-term intake of high dietary fat (5 days) compared to low fat intake (5 days) in a cross-over design in older adults (men and women) with normal body weight or obesity. Inflammation will be examined by measuring serum endotoxin and other markers, as well as the fecal microbiota.

Interventions

  • OTHER Low Fat Diet (LFD)
  • OTHER High Fat Diet (HFD)

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-03-01
Est. Completion 2023-02-11
Phase NA

What the Registry Record Tells You About NCT05327868

The ClinicalTrials.gov registry entry for NCT05327868 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Low Fat Diet (LFD) is the first listed.

NCT05327868 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05327868 about?

NCT05327868 is a clinical study titled "Lean and Obese: Dietary Inflammation". In the Lean and Obese Dietary Inflammation (LODI) study, the primary goal is to determine the effect of short-term intake of high dietary fat (5 days) compared to low fat intake (5 days) in a cross-over design in older adults (men and women) with normal body weight or obesity. Inflammation will be e...

What is the current status of trial NCT05327868?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-03-01. Estimated completion is 2023-02-11.

What interventions are being tested in trial NCT05327868?

The interventions under investigation include: Low Fat Diet (LFD) (OTHER), High Fat Diet (HFD) (OTHER).

Who is sponsoring clinical trial NCT05327868?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.